Announced the departure of Nitin Sood, Chief Commercial Officer, CCO, of the MRD business, who will be pursuing a new opportunity outside of the company. Sood’s position will not be replaced. Susan Bobulsky, who has led the clinical business for the past five years, will assume additional responsibilities and report directly to Chad Robins.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ADPT:
- Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results
- Adaptive Biotechnologies management to meet virtually with Piper Sandler
- ADPT Earnings this Week: How Will it Perform?
- Cathie Wood’s ARK Investment bought 170K Adaptive Biotechnologies shares today
- Adaptive Biotechnologies to Report Second Quarter Financial Results on August 2, 2023